Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RECOVER-HF - RandomizEd, Multi-Center, Double-Blinded Study of SynchrOnized Diaphragmatic Stimulation (SDS) for ImproVEment of Symptomatic Reduced Ejection Fraction Heart Failure

NCT06552637 is registered in ClinicalTrials.gov with VisCardia Inc. as lead sponsor.

NCT NCT06552637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06552637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RECOVER-HF - RandomizEd, Multi-Center, Double-Blinded Study of SynchrOnized Diaphragmatic Stimulation (SDS) for ImproVEment of Symptomatic Reduced Ejection Fraction Heart Failure
Lead sponsor
VisCardia Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
July 8, 2026
Completion date
December 31, 2029
Enrollment
270 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with reduced ejection fraction